pathophys of type 1 diabetes Flashcards
T1D associated comorbidities
autoimmune disorders (thyroid, celiac, addisons dz), macrovascular dz, microvascular dz, psychosocial
prevalance of T1D by age 20 in general population, first degree relatives, monozygotic twins
general pop- 1:300. first degree relative - 1:20. Monozygotic twins- 1:3 to 1:11
Diabetes is a disease of T or B cells?
T cells! CD4 and CD8
Describe the linear chronic model of type 1 diabetes
Genetic predisposition > precipitating event (?) > T cell attack of beta cells in pancreas (normal insulin release) > progressive loss of insulin release but normal glucose > overt diabetes but C-peptide present > no C peptide anymore
- Define the four autoantigens that are characteristic of TID.
insulin, glutamic acid decarboxylase 65 (GAD65), tyrosine phosphatase like protein (IA-2), and a zinc transporter (ZnT8).
What is the islet cell autoantibody
antibody against the characteristic antigens of T1D.
How does autoantibody numbers correlate with disease progression
With > 2 islet autoantibodies, individuals will eventually progress to T1D with overt hyperglycemia.
- Predict the likelihood of progression to TID given the presence of 1, 2, or 3 autoantibodies in a child over the ensuing 10 years.
1: in 10 years, 20% develop diabetes. 2: in 10 years, 70% develop diabetes. 3: in 10 years 70% develop diabetes
First metabolic abnormalities to develop in T1D
states in which the most insulin is required- ie. Decrease in first phase insulin response of a IV glucose tolerance test. This can occur years prior to development of T1D.
Oral glucose tolerance testing procedure
Fasting subjects receive a carbohydrate load (glucola) and glucose is measured fasting and 2 hours after the glucose load
diagnosis of diabetes
single blood glucose greater than 200 mg/dL in the presence of symptoms of hyperglycemia OR fasting glucose >125mg/dl OR 2hr OGTT >199mg/dL
normal blood glucose and 2hr OGTT
fasting <140mg/dl
When do pts present with symptoms of diabetes
when 80-90% of Beta cell mass has been destroyed
Genetic risk of T1D
80% diagnosed do NOT have relative with T1D. Risk is increased in siblings and offspring though.
List the genes associated with T1D risk
HLA and insulin gene
Which HLA genes are associated with T1D
HLA DR3/4 is highest risk. Subjects who express this genotype have a risk for the development of T1D by age 20 years of 1:15. First-degree relatives with this genotype have a risk for diabetes of up to 50%.
Genes protective for T1D
DQA10102, DQB10602. Only 3% with this genotype develop dz, compared to 20% of population
How is the insulin gene associated with risk of T1D
variable number of tandem repeats (VNTR) within the 5’ region of the insulin gene has been associated with risk of T1D. Class 1 (26-63 repeats) is associated with increased risk and class III (140-200 repeats) is associated with decreased risk. Higher classes are incrased in expression in thymus leading to T cell tolerance to insulin
T1D genetic additive effects
Subjects with DR3/4 HLA genotypes and Class I/I VNTR of the insulin gene are at an increased risk for the development of diabetes compared with subjects with DR3/4 HLA genotypes and Class III VNTR of the insulin gene.
possible environemental factors in T1D
hygeine hypothesis: immune system is bored from too few infections leading to autoimmunity. Diet: increased risk related to shorter duration of breastfeeding, earlier introduction of cows milk and cereals, and Vit D/ omega-3 fatty acids may be protective. Accelerator hypothesis: increased childhood obesity may be linked to increased incidence by causing beta cell stress and exposing beta cell Ags to immune system
how are immunizations associated with T1D
They are not!
What is latent autoimmune diabetes of adulthood
Diagnosed at 30-70 years, at least 6 months of non-insulin requiring diabetes and presence of diabetes associated with autoantibodies. It is inbetween type 1 and type 2 diabetes.
Predictors of insulin requirement
Insulin rquirement increases with autoantibodies and age
Metabolism in T1D
Decreased glucose transport into cells, increased glucose production via glycogen and gluconeogenesis, and increased activity of hormone sensitive lipase resulting in mobilization of FFA and ketones
name 3 therapies approved for T1D
Continuous glucose monitoring systems, insulins and continuous subcutaneous insulin infusion